Advertisement
TULSA, Okla., Jan. 10, 2019 /PRNewswire-PRWeb/ -- Verinovum, a health data enrichment and integration technology company, has partnered with the George Kaiser Family Foundation (GKFF) to create a joint vision to improve the health and well-being of patients across their lifespan.
Since December 2017, GKFF has served as a series A investor in Verinovum, acknowledging the contribution that Verinovum's technology brings to GKFF's philosophy that all people deserve an equal opportunity and access to high-quality and affordable healthcare.
GKFF is a philanthropic organization focused on initiatives that work to reverse the generational cycle of poverty, especially for young children and their families, by eliminating health disparities and working to increase access to quality health care for low-income families and underserved communities. The foundation has a $3.75B investment portfolio which is globally diversified.
"Verinovum's expertise and passion for advancing healthcare make them a natural fit with our organization. And, it's an added bonus that they're based right in our backyard, making a difference in Tulsa as well as across the nation," says Robert Thomas, GKFF's Chief Investment Officer. "Their unique approach to curating healthcare data delivers the actionable information needed to reduce costs and impact quality of care, which is why we're excited to be an investor and to serve on the board."
Verinovum's Data Enrichment and Interchange technology focuses on aggregation, normalization and enrichment of data from disparate sources, enabling accountable care organizations, clinically integrated networks, and payers to improve both business and care outcomes by delivering actionable information.
"GKFF believes that every child and family deserve access to the best healthcare available, and at Verinovum, we are committed to providing the highest quality of data needed to make that happen," says Mark McCurry, Verinovum CEO. "GKFF's investment in Verinovum is helping to usher in the next generation of healthcare innovation—the actionable data that is the foundation for analytics, artificial intelligence, and whatever comes next."
About Verinovum Verinovum builds foundational technology to support the healthcare industry. The company is a market leader of clinical and claims data cleansing and remediation, enabling accountable care organizations, clinically integrated networks, and payers to improve operating performance and quality by delivering actionable information. Verinovum's Data Enrichment and Interchange Platform-as-a-Service (PaaS) supports regional data efforts across the United States. By focusing on aggregation, normalization and enrichment of data from disparate sources, the platform facilitates health data interchange, community-wide care coordination, and decision support in pursuit of the triple aim (better outcomes, better experiences, and lower costs). Learn more at verinovum.com.
SOURCE Verinovum
Advertisement
Since December 2017, GKFF has served as a series A investor in Verinovum, acknowledging the contribution that Verinovum's technology brings to GKFF's philosophy that all people deserve an equal opportunity and access to high-quality and affordable healthcare.
GKFF is a philanthropic organization focused on initiatives that work to reverse the generational cycle of poverty, especially for young children and their families, by eliminating health disparities and working to increase access to quality health care for low-income families and underserved communities. The foundation has a $3.75B investment portfolio which is globally diversified.
"Verinovum's expertise and passion for advancing healthcare make them a natural fit with our organization. And, it's an added bonus that they're based right in our backyard, making a difference in Tulsa as well as across the nation," says Robert Thomas, GKFF's Chief Investment Officer. "Their unique approach to curating healthcare data delivers the actionable information needed to reduce costs and impact quality of care, which is why we're excited to be an investor and to serve on the board."
Verinovum's Data Enrichment and Interchange technology focuses on aggregation, normalization and enrichment of data from disparate sources, enabling accountable care organizations, clinically integrated networks, and payers to improve both business and care outcomes by delivering actionable information.
"GKFF believes that every child and family deserve access to the best healthcare available, and at Verinovum, we are committed to providing the highest quality of data needed to make that happen," says Mark McCurry, Verinovum CEO. "GKFF's investment in Verinovum is helping to usher in the next generation of healthcare innovation—the actionable data that is the foundation for analytics, artificial intelligence, and whatever comes next."
About Verinovum Verinovum builds foundational technology to support the healthcare industry. The company is a market leader of clinical and claims data cleansing and remediation, enabling accountable care organizations, clinically integrated networks, and payers to improve operating performance and quality by delivering actionable information. Verinovum's Data Enrichment and Interchange Platform-as-a-Service (PaaS) supports regional data efforts across the United States. By focusing on aggregation, normalization and enrichment of data from disparate sources, the platform facilitates health data interchange, community-wide care coordination, and decision support in pursuit of the triple aim (better outcomes, better experiences, and lower costs). Learn more at verinovum.com.
SOURCE Verinovum
